Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001946043-22-000001
Filing Date
2022-09-13
Accepted
2022-09-13 15:49:51
Documents
1
Period of Report
2022-09-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1469
  Complete submission text file 0001946043-22-000001.txt   2879
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Issuer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: NJ | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 165 LUDLOW AVE NORTHVALE NJ 07647
Business Address
Kirkov Kirko (Reporting) CIK: 0001946043 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15697 | Film No.: 221240681